3SHE

Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.246 
  • R-Value Observed: 0.248 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series.

Oubrie, A.Kaptein, A.de Zwart, E.Hoogenboom, N.Goorden, R.van de Kar, B.van Hoek, M.de Kimpe, V.van der Heijden, R.Borsboom, J.Kazemier, B.de Roos, J.Scheffers, M.Lommerse, J.Schultz-Fademrecht, C.Barf, T.

(2012) Bioorg Med Chem Lett 22: 613-618

  • DOI: 10.1016/j.bmcl.2011.10.071
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-induced production of the cytokine TNFα is coupled to the regulation of HSP27 phosphorylation, indicating that the observed cellular effects result from the inhibition of MK2 ...

    Optimization of our previously described pyrrolopiperidone series led to the identification of a new benzamide sub-series, which exhibits consistently high potency in biochemical and cell-based assays throughout the series. Strong inhibition of LPS-induced production of the cytokine TNFα is coupled to the regulation of HSP27 phosphorylation, indicating that the observed cellular effects result from the inhibition of MK2. X-ray crystallographic and computational analyses provide a rationale for the high potency of the series.


    Organizational Affiliation

    Merck Research Laboratories, MSD, PO Box 20, 5340 BH Oss, The Netherlands.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
MAP kinase-activated protein kinase 3A317Homo sapiensMutation(s): 0 
Gene Names: MAPKAPK3
EC: 2.7.11.1
Find proteins for Q16644 (Homo sapiens)
Explore Q16644 
Go to UniProtKB:  Q16644
NIH Common Fund Data Resources
PHAROS  Q16644
Protein Feature View
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
I85
Query on I85

Download CCD File 
A
N-{4-[(3S)-4'-oxo-1',4',5',6'-tetrahydrospiro[piperidine-3,7'-pyrrolo[3,2-c]pyridin]-2'-yl]pyridin-2-yl}-3-(trifluoromethyl)benzamide
C24 H22 F3 N5 O2
FEVPBNYNYKIJAR-QHCPKHFHSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 0.271 
  • R-Value Work: 0.246 
  • R-Value Observed: 0.248 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 83.946α = 90
b = 76.026β = 106.68
c = 60.288γ = 90
Software Package:
Software NamePurpose
ADSCdata collection
REFMACrefinement
d*TREKdata reduction
d*TREKdata scaling
REFMACphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2011-12-14
    Type: Initial release
  • Version 1.1: 2012-01-11
    Changes: Database references